Paclitaxel Fresenius 30 mg/5 ml

Paclitaxel Fresenius 30 mg/5 ml is a medicine authorised by Swissmedic under authorisation number 63049. The authorisation holder is Fresenius Kabi (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 29 April 2014 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.

  • Dispensing category A
  • Authorisation number 63049
  • Synthetic medicines
Authorisation data
Authorisation number63049
NamePaclitaxel Fresenius 30 mg/5 ml
Full namePaclitaxel Fresenius 30 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderFresenius Kabi (Schweiz) AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codenot stated
First authorisation29 April 2014
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Paclitaxel Fresenius 30 mg/5 ml, Konzentrat zur Herstellung einer InfusionslösungA29 April 2014
2Paclitaxel Fresenius 100 mg/16.7 ml, Konzentrat zur Herstellung einer InfusionslösungA29 April 2014
3Paclitaxel Fresenius 300 mg/50 ml, Konzentrat zur Herstellung einer InfusionslösungA29 April 2014

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
The Swissmedic export lists no pack sizes for this medicine.

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Paclitaxel Fresenius 30 mg/5 ml authorised in Switzerland?

Yes. Paclitaxel Fresenius 30 mg/5 ml is authorised by Swissmedic under authorisation number 63049, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Paclitaxel Fresenius 30 mg/5 ml have?

Paclitaxel Fresenius 30 mg/5 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Paclitaxel Fresenius 30 mg/5 ml?

The authorisation holder is Fresenius Kabi (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com